patents

charpentier-doudna

Who Owns CRISPR? Understanding the Confusion Around This Revolutionary Tech

The Wire Staff 11/03/2022

The US Patent and Trademark Office ruled on February...

6961051384_2c5c9cb703_k

Sci-Hub: Journals Must Stop Exploiting Research for Profits

Raja Singh 06/10/2021

Researchers in India must have access to all research...

money-reuters-660-1

Expenses of Science, Health, Environment Departments of Interest, 2014-2019

The Wire Staff 01/02/2021

Union finance minister Nirmala Sitharaman will present the 2021-2022...

anastasiia-ostapovych-irvotzaouA4-unsplashf

Diabetes Drug Dapagliflozin Needs To Brace for Price War, Analysts Say

E. Kumar Sharma 07/10/2020

A drug with multiple benefits is stuck between prospects...

Screenshot 2020-10-07 at 8.37.58 AM

Medicine Nobel for Hep C Should Force Us to Think About Patents, Patients, Profits

Vasudevan Mukunth 07/10/2020

The intertwined stories of HCV infections and sofosbuvir illustrate...

107th Indian Science Congress, Indian Science Congress, Prime Minister Narendra Modi, Council of Scientific and Industrial Research, patents, National Chemical Laboratory, Central Drug Research Institute, Shekhar Mande, Girish Sahni, fundamental research, applied research, INSPIRE-SHE, March for Science, R&D, GERD, arteether, Central University of Kerala, University of Hyderabad, Department of Atomic Energy, Tata Institute of Fundamental Research

Narendra Modi’s Focus on Patents at Indian Science Congress Is Not Good Advice

Vasudevan Mukunth 03/01/2020

The Narendra Modi government's push to have research institutions...

Department of Science and Technology, Department of Biotechnology, QuEST, quantum computing, Indian quantum computing, 3D printing, internet of things, artificial intelligence, data is the new oil, #Budget2020, 2020 union budget, R&D, Department of Space, Chandrayaan 3, Gaganyaan, human spaceflight, Indian Space Research Organisation, ISRO, Aditya L1, Renu Swarup, quantum cryptography,

The State Helps Float Risky Medical Research. Why Don’t Patents Benefit It?

Dr Samir Malhotra 26/12/2019

Before pharma companies can build on existing knowledge to...